methyl (2alpha)-14-[(3aR,6R)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-yl]-13-hydroxyibogamine-18-carboxylate (60820-65-7)

Identification
Name:	methyl (2alpha)-14-[(3aR,6R)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-yl]-13-hydroxyibogamine-18-carboxylate
Synonyms:	Bonafousine;C09050;AC1L9C2H;60820-65-7
CAS:	60820-65-7
Molecular Formula:	C₃₅H₄₀N₄O₃
Molecular Weight:	564.7171
InChI:	InChI=1/C35H40N4O3/c1-3-20-16-19-17-35(34(41)42-2)32-24(13-15-38(18-19)33(20)35)22-8-11-28(40)29(30(22)37-32)27-10-9-25-31-23(12-14-36-25)21-6-4-5-7-26(21)39(27)31/h4-8,11,19-20,25,27,33,36-37,40H,3,9-10,12-18H2,1-2H3/t19-,20-,25+,27+,33-,35+/m0/s1
Molecular Structure:
Properties
Density:	1.5g/cm³
Refractive index:	1.788
Safety Data

Other Product

Ibogamine-18-methanol,14-[(3aR,6R)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-yl]-13-hydroxy-(9CI)
Ibogamine-18-methanol,14-[(2R,3aR)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-2-yl]-13-hydroxy-(9CI)
Ibogamine-18-carboxylicacid,14-[(2R,3aR)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-2-yl]-13-hydroxy-,methyl ester (9CI)
3-methyl-6-prop-2-en-1-yl-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-ol
ethyl 2-((3aR,4S)-4-ethyl-4-(2-methoxy-2-oxoethyl)-6-oxo-3a,4,5,6-tetrahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-3(2H)-yl)acetate
methyl (3aR,4S)-6-oxo-3-(3-oxobutyl)-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridine-4-carboxylate methanesulfonate
methyl (3aR,4S)-10-fluoro-3-methyl-6-oxo-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridine-4-carboxylate
methyl (3aR,4S)-3-methyl-6-oxo-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridine-4-carboxylate methanesulfonate
3-prop-2-en-1-yl-1,2,3,3a,4,5-hexahydro-6H-indolo[3,2,1-de][1,5]naphthyridin-6-one hydrochloride
3-[(2E)-but-2-en-1-yl]-1,2,3,3a,4,5-hexahydro-6H-indolo[3,2,1-de][1,5]naphthyridin-6-one hydrochloride
3-prop-2-yn-1-yl-1,2,3,3a,4,5-hexahydro-6H-indolo[3,2,1-de][1,5]naphthyridin-6-one hydrochloride
methyl (2alpha)-12-[(2R,5E,6R,8R)-5-ethylidene-14-(methoxycarbonyl)-2,3,4,5,6,7,8,9-octahydro-1H-2,6-methanoazecino[5,4-b]indol-8-yl]-13-methoxyibogamine-18-carboxylate
methyl (2alpha)-13-[(2R,5E,6R,8R)-5-ethylidene-14-(methoxycarbonyl)-2,3,4,5,6,7,8,9-octahydro-1H-2,6-methanoazecino[5,4-b]indol-8-yl]-12-methoxyibogamine-18-carboxylate
(3aR)-3-[(3R)-3-hydroxybutyl]-1,2,3,3a,4,5-hexahydro-6H-indolo[3,2,1-de][1,5]naphthyridin-6-one
1,3-Benzodioxole-5-carboxaldehyde,6-[(3S,3aR,6R,7aR)-1,2,3,6,7,7a-hexahydro-3-hydroxy-6-methoxy-1-methyl-3aH-indol-3a-yl]-4-methoxy-
3-ethyl-6-methyl-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-ol
6-ethyl-3-methyl-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-ol
6-methyl-3-propyl-2,3,3a,4,5,6-hexahydro-1H-indolo[3,2,1-de][1,5]naphthyridin-6-ol
2(5H)-Furanone,5-[[(1S,3aR,4R,6R)-1,2,3,4,5,6-hexahydro-1,5,5-trimethyl-3a,6-ethano-3aH-inden-4-yl]methylene]-3-methyl-,(5Z)- (9CI)
1/C14H15O3P/c15-18(16-11-13-7-3-1-4-8-13)17-12-14-9-5-2-6-10-14/h1-10,18H,11-12H